Business Description
Galapagos NV
ISIN : US36315X1019
Share Class Description:
GLPG: ADRCompare
Compare
Traded in other countries / regions
GLPG.USAGLPG.Netherlands0JXZ.UKGXEA.GermanyG1LP34.BrazilGLPG.AustriaGLPG.BelgiumGLPG.Mexico IPO Date
2015-05-13Description
Galapagos NV is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 251.37 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.49 | |||||
| Beneish M-Score | -1.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -17.9 | |||||
| 3-Year Book Growth Rate | -4.8 | |||||
| Future 3-5Y Total Revenue Growth Rate | 1.82 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.83 | |||||
| 9-Day RSI | 18.5 | |||||
| 14-Day RSI | 20.46 | |||||
| 6-1 Month Momentum % | -0.05 | |||||
| 12-1 Month Momentum % | -11.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.49 | |||||
| Quick Ratio | 8.38 | |||||
| Cash Ratio | 8.16 | |||||
| Days Inventory | 1046.61 | |||||
| Days Sales Outstanding | 25.17 | |||||
| Days Payable | 3736.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.6 | |||||
| Shareholder Yield % | 0.27 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.43 | |||||
| Operating Margin % | -28.34 | |||||
| Net Margin % | -28.09 | |||||
| ROE % | -6.05 | |||||
| ROA % | -3.29 | |||||
| ROIC % | -20.11 | |||||
| ROC (Joel Greenblatt) % | -99.42 | |||||
| ROCE % | -3.38 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 90.31 | |||||
| PS Ratio | 3.83 | |||||
| PB Ratio | 0.83 | |||||
| Price-to-Tangible-Book | 0.9 | |||||
| EV-to-EBIT | 11.89 | |||||
| EV-to-EBITDA | 14.64 | |||||
| EV-to-Revenue | -3.1 | |||||
| EV-to-FCF | 3.16 | |||||
| Price-to-Projected-FCF | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 1.03 | |||||
| Price-to-Net-Cash | 1.11 | |||||
| Earnings Yield (Greenblatt) % | 8.41 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GLPG
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Galapagos NV Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 589.587 | ||
| EPS (TTM) ($) | -2.558 | ||
| Beta | 0.04 | ||
| Volatility % | 31.77 | ||
| 14-Day RSI | 20.46 | ||
| 14-Day ATR ($) | 0.551531 | ||
| 20-Day SMA ($) | 35.5525 | ||
| 12-1 Month Momentum % | -11.18 | ||
| 52-Week Range ($) | 33.69 - 48.07 | ||
| Shares Outstanding (Mil) | 65.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galapagos NV Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Galapagos NV Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Galapagos NV Frequently Asked Questions
What is Galapagos NV(GLPG)'s stock price today?
The current price of GLPG is $33.98. The 52 week high of GLPG is $48.07 and 52 week low is $33.69.
When is next earnings date of Galapagos NV(GLPG)?
The next earnings date of Galapagos NV(GLPG) is 2023-11-02.
Does Galapagos NV(GLPG) pay dividends? If so, how much?
Galapagos NV(GLPG) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers